Stockholders' Equity (Narrative) (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Oct. 01, 2025 |
Oct. 22, 2025 |
May 25, 2025 |
Apr. 15, 2025 |
Dec. 16, 2024 |
Nov. 28, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Class of Stock [Line Items] | ||||||||
| Common stock, par value per share | $ 0.001 | $ 0.001 | ||||||
| Common stock, Shares Authorized | 200,000,000 | 200,000,000 | ||||||
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | ||||||
| Preferred stock, par value per share | $ 0.0001 | $ 0.0001 | ||||||
| Warrant outstanding | 22,400,000 | 12,400,000 | ||||||
| Weighted average exercise price | $ 0.18 | $ 0.1 | ||||||
| Weighted average life of warrants | 1 year 8 months 23 days | |||||||
| Private Placement [Member] | ||||||||
| Class of Stock [Line Items] | ||||||||
| Shares issued in transaction | 10,000,000 | 10,000,000,000 | 10,000,000 | 12,400,000,000 | ||||
| Private placement financing | $ 620,000 | $ 700,000 | ||||||
| Shares issued price per share | $ 0.25 | $ 0.12 | $ 0.05 | |||||
| Description of transaction | Each unit includes one share of common stock and one-half warrant to purchase one share of common stock, exercisable for 2 years from the close of the offering at an exercise price of $0.40. | Each unit includes one share of common stock and one-half warrant to purchase one share of common stock, exercisable for 2 years from the close of the offering at an exercise price of $0.18 per share. | Each unit consisted of one share of common stock and one common stock purchase warrant, with each warrant exercisable for one additional share at $0.10 per share for 36 months from issuance. | |||||
| Weighted average exercise price | $ 0.4 | $ 0.18 | $ 0.1 | |||||
| Proceeds from private placement | $ 2,500,000 | $ 1,200,000 | ||||||
| Non-cash consideration for vendor services | $ 20,000 | |||||||
| Proceeds from issuing equity | $ 1,200,000 | |||||||
| Subscription agreement [Member] | ||||||||
| Class of Stock [Line Items] | ||||||||
| Shares issued in transaction | 200,000 | |||||||
| Warrants granted during period | $ 100,000 | |||||||
| Proceeds from issuing equity | $ 50,000 | |||||||
| X | ||||||||||
- Definition It represets non-cash consideration for vendor services. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of warrants granted during period. No definition available.
|
| X | ||||||||||
- Definition weighted average life of warrants. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|